118 related articles for article (PubMed ID: 36394079)
21. APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry.
Xuan D; Li G; Cai Q; Deming-Halverson S; Shrubsole MJ; Shu XO; Kelley MC; Zheng W; Long J
Carcinogenesis; 2013 Oct; 34(10):2240-3. PubMed ID: 23715497
[TBL] [Abstract][Full Text] [Related]
22. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
[TBL] [Abstract][Full Text] [Related]
23. Impact of
Helwa R; Gansmo LB; Bjørnslett M; Halle MK; Werner HMJ; Romundstad P; Hveem K; Vatten L; Dørum A; Lønning PE; Knappskog S
Biomarkers; 2021 Jun; 26(4):302-308. PubMed ID: 33645339
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional repression and apoptosis influence the effect of APOBEC3A/3B functional polymorphisms on biliary tract cancer risk.
Liu W; Ji H; Zhao J; Song J; Zheng S; Chen L; Li P; Tan X; Ding Y; Pu R; Yin J; Han X; Cao G
Int J Cancer; 2022 Jun; 150(11):1825-1837. PubMed ID: 35020946
[TBL] [Abstract][Full Text] [Related]
25. Distinct Mutagenic Activity of APOBEC3G Cytidine Deaminase Identified in Bladder Cancer.
Caswell D; Swanton C
Cancer Res; 2023 Feb; 83(4):487-488. PubMed ID: 36789568
[TBL] [Abstract][Full Text] [Related]
26. APOBEC3B deletion impacts on susceptibility to acquire HIV-1 and its advancement among individuals in western India.
Singh H; Marathe SD; Nain S; Nema V; Ghate MV; Gangakhedkar RR
APMIS; 2016 Oct; 124(10):881-7. PubMed ID: 27522954
[TBL] [Abstract][Full Text] [Related]
27. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
[TBL] [Abstract][Full Text] [Related]
28. The APOBEC3B deletion polymorphism is associated with prevalence of hepatitis B virus, hepatitis C virus, Torque Teno virus, and Toxoplasma gondii co-infection among HIV-infected individuals.
Prasetyo AA; Sariyatun R; Reviono ; Sari Y; Hudiyono ; Haryati S; Adnan ZA; Hartono ; Kageyama S
J Clin Virol; 2015 Sep; 70():67-71. PubMed ID: 26305823
[TBL] [Abstract][Full Text] [Related]
29. Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population.
He X; Xu H; Wang X; Wu J; Niu J; Gao P
Mol Med Rep; 2019 Sep; 20(3):2177-2188. PubMed ID: 31322199
[TBL] [Abstract][Full Text] [Related]
30. No association between FTO or HHEX and endometrial cancer risk.
Gaudet MM; Yang HP; Bosquet JG; Healey CS; Ahmed S; Dunning AM; Easton DF; Spurdle AB; Ferguson K; O'Mara T; Lambrechts D; Despierre E; Vergote I; Amant F; Lacey JV; Lissowska J; Peplonska B; Brinton LA; Chanock S; Garcia-Closas M
Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2106-9. PubMed ID: 20647405
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.
Lee E; Hsu C; Haiman CA; Razavi P; Horn-Ross PL; Van Den Berg D; Bernstein L; Le Marchand L; Henderson BE; Setiawan VW; Ursin G
Carcinogenesis; 2010 Aug; 31(8):1392-9. PubMed ID: 20547493
[TBL] [Abstract][Full Text] [Related]
32. APOBEC mediated mutagenesis drives genomic heterogeneity in endometriosis.
Revathidevi S; Nakaoka H; Suda K; Fujito N; Munirajan AK; Yoshihara K; Enomoto T; Inoue I
J Hum Genet; 2022 Jun; 67(6):323-329. PubMed ID: 35017684
[TBL] [Abstract][Full Text] [Related]
33. MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk.
Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Romundstad P; Hveem K; Vatten L; Dørum A; Lønning PE; Knappskog S
BMC Cancer; 2017 Feb; 17(1):97. PubMed ID: 28158999
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of an APOBEC3 deletion polymorphism for glioma patients in Taiwan.
Chen CH; Wei KC; Liao WC; Lin YY; Chen HC; Feng LY; Liu CH; Huang CY; Chen KT; Wu CS; Chang YS; Yu JS; Chang IY
J Neurosurg; 2023 May; 138(5):1325-1337. PubMed ID: 36152319
[TBL] [Abstract][Full Text] [Related]
35. Association between MDM2 SNP309 and endometrial cancer risk: A PRISMA-compliant meta-analysis.
Zou X; Zhang Y; Zhang L; Li J; Zhu C; Cheng Q; Zhou J; Chen Y
Medicine (Baltimore); 2018 Dec; 97(49):e13273. PubMed ID: 30544386
[TBL] [Abstract][Full Text] [Related]
36. Population stratification of a common APOBEC gene deletion polymorphism.
Kidd JM; Newman TL; Tuzun E; Kaul R; Eichler EE
PLoS Genet; 2007 Apr; 3(4):e63. PubMed ID: 17447845
[TBL] [Abstract][Full Text] [Related]
37. Estrogen receptor alpha gene polymorphism and endometrial cancer risk--a case-control study.
Wedrén S; Lovmar L; Humphreys K; Magnusson C; Melhus H; Syvänen AC; Kindmark A; Landegren U; Fermér ML; Stiger F; Persson I; Baron JA; Weiderpass E
BMC Cancer; 2008 Nov; 8():322. PubMed ID: 18990228
[TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphisms in obesity-related genes and endometrial cancer risk.
Chen X; Xiang YB; Long JR; Cai H; Cai Q; Cheng J; Wen W; Gao YT; Zheng W; Shu XO
Cancer; 2012 Jul; 118(13):3356-64. PubMed ID: 22038736
[TBL] [Abstract][Full Text] [Related]
39. MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.
Li Y; Zhao H; Sun L; Huang L; Yang Q; Kong B
Hum Cell; 2011 Jun; 24(2):57-64. PubMed ID: 21547352
[TBL] [Abstract][Full Text] [Related]
40. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo.
Law EK; Levin-Klein R; Jarvis MC; Kim H; Argyris PP; Carpenter MA; Starrett GJ; Temiz NA; Larson LK; Durfee C; Burns MB; Vogel RI; Stavrou S; Aguilera AN; Wagner S; Largaespada DA; Starr TK; Ross SR; Harris RS
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32870257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
